Folate/ja: Difference between revisions
Folate/ja
Created page with "{{Infobox drug | drug_name = Folic acid | image = Folic acid.svg | width = 260 | alt = 骨格式 | caption = | image2 = Folic-acid-from-xtal-3D-bs-17.png | width2 = 280 | alt2 =" Tags: Mobile edit Mobile web edit |
Created page with "<!-- Chemical and physical data --> | IUPAC_name = (2''S'')-2-<nowiki>[[</nowiki>4-[(2-Amino-4-oxo-1''H''-pteridin-6-yl)methylamino]benzoyl]amino]pentanedioic acid | C = 19 | H = 19 | N = 7 | O = 6 | SMILES = n1c2C(=O)NC(N)=Nc2ncc1CNc3ccc(cc3)C(=O)N[C@H](C(O)=O)CCC(O)=O | StdInChI = 1S/C19H19N7O6/c20-19-25-15-14(17(30)26-19)23-11(8-22-15)7-21-10-3-1-9(2-4-10)16(29)24-12(18(31)32)5-6-13(27)28/h1-4,8,12,21H,5-7H2,(H,24,29)(H,27,28)(H,31,32)(H3,20,22,25,26,30)/t12-/m0/s1 |..." Tags: Mobile edit Mobile web edit |
||
Line 10: | Line 10: | ||
| alt2 = | | alt2 = | ||
<!-- Clinical data --> | <!-- Clinical data --> | ||
| pronounce = {{IPAc-en|ˈ|f|oʊ|l|ɪ|k|,_|ˈ|f|ɒ|l|ɪ|k}} | | pronounce = {{IPAc-en|ˈ|f|oʊ|l|ɪ|k|,_|ˈ|f|ɒ|l|ɪ|k}} | ||
Line 20: | Line 19: | ||
| pregnancy_AU_comment = | | pregnancy_AU_comment = | ||
| pregnancy_category = | | pregnancy_category = | ||
| routes_of_administration = [[Oral administration| | | routes_of_administration = [[Oral administration/ja|口から]], [[Intramuscular injection/ja|筋肉内]], [[Intravenous therapy/ja|静脈内]], [[Subcutaneous injection/ja|皮下]] | ||
| class = | | class = | ||
| ATC_prefix = B03 | | ATC_prefix = B03 | ||
| ATC_suffix = BB01 | | ATC_suffix = BB01 | ||
| ATC_supplemental = {{ATC|V04|CX02}} {{ATC|B03|AE02}} {{ATC|B03|AE01}} {{ATC|B03|BB51}} | | ATC_supplemental = {{ATC|V04|CX02}} {{ATC|B03|AE02}} {{ATC|B03|AE01}} {{ATC|B03|BB51}} | ||
<!-- Legal status --> | <!-- Legal status --> | ||
| legal_AU = S4 | | legal_AU = S4 | ||
Line 48: | Line 45: | ||
| legal_UN_comment = | | legal_UN_comment = | ||
| legal_status = <!-- For countries not listed above --> | | legal_status = <!-- For countries not listed above --> | ||
<!-- Pharmacokinetic data --> | <!-- Pharmacokinetic data --> | ||
| bioavailability = 50–100% | | bioavailability = 50–100% | ||
| protein_bound = | | protein_bound = | ||
| metabolism = [[Liver]] | | metabolism = [[Liver/ja]] | ||
| metabolites = | | metabolites = | ||
| onset = | | onset = | ||
Line 60: | Line 55: | ||
| duration_of_action = | | duration_of_action = | ||
| excretion = Urine | | excretion = Urine | ||
<!-- Identifiers --> | <!-- Identifiers --> | ||
| index2_label = as salt | | index2_label = as salt | ||
Line 83: | Line 76: | ||
| PDB_ligand = FOL | | PDB_ligand = FOL | ||
| synonyms = Wills factor, FA, ''N''-(4-<nowiki/>{[(2-amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]amino}benzoyl)-<small>L</small>-glutamic acid, pteroyl-L-glutamic acid, folacin, vitamin B<sub>9</sub>; formerly, vitamin B<sub>c</sub> and vitamin M | | synonyms = Wills factor, FA, ''N''-(4-<nowiki/>{[(2-amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]amino}benzoyl)-<small>L</small>-glutamic acid, pteroyl-L-glutamic acid, folacin, vitamin B<sub>9</sub>; formerly, vitamin B<sub>c</sub> and vitamin M | ||
<!-- Chemical and physical data --> | <!-- Chemical and physical data --> | ||
| IUPAC_name = (2''S'')-2-<nowiki>[[</nowiki>4-[(2-Amino-4-oxo-1''H''-pteridin-6-yl)methylamino]benzoyl]amino]pentanedioic acid | | IUPAC_name = (2''S'')-2-<nowiki>[[</nowiki>4-[(2-Amino-4-oxo-1''H''-pteridin-6-yl)methylamino]benzoyl]amino]pentanedioic acid | ||
Line 104: | Line 95: | ||
| specific_rotation = | | specific_rotation = | ||
}} | }} | ||
<div lang="en" dir="ltr" class="mw-content-ltr"> | <div lang="en" dir="ltr" class="mw-content-ltr"> |